CA2628806C - Injectable liquid paracetamol formulation - Google Patents

Injectable liquid paracetamol formulation Download PDF

Info

Publication number
CA2628806C
CA2628806C CA2628806A CA2628806A CA2628806C CA 2628806 C CA2628806 C CA 2628806C CA 2628806 A CA2628806 A CA 2628806A CA 2628806 A CA2628806 A CA 2628806A CA 2628806 C CA2628806 C CA 2628806C
Authority
CA
Canada
Prior art keywords
paracetamol
solution
aqueous
solution according
color
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2628806A
Other languages
English (en)
French (fr)
Other versions
CA2628806A1 (en
Inventor
Faustino Huertas Munoz
Raul Fernandez Plagaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altan Pharma Ltd
Original Assignee
Genfarma Laboratorio SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38474429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2628806(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genfarma Laboratorio SL filed Critical Genfarma Laboratorio SL
Publication of CA2628806A1 publication Critical patent/CA2628806A1/en
Application granted granted Critical
Publication of CA2628806C publication Critical patent/CA2628806C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
CA2628806A 2006-07-18 2006-07-18 Injectable liquid paracetamol formulation Active CA2628806C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2006/070108 WO2008009756A1 (es) 2006-07-18 2006-07-18 Formulación líquida inyectable de paracetamol

Publications (2)

Publication Number Publication Date
CA2628806A1 CA2628806A1 (en) 2008-01-24
CA2628806C true CA2628806C (en) 2012-08-21

Family

ID=38474429

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2628806A Active CA2628806C (en) 2006-07-18 2006-07-18 Injectable liquid paracetamol formulation

Country Status (17)

Country Link
US (2) US9943479B2 (https=)
EP (2) EP2100596A3 (https=)
JP (1) JP4929352B2 (https=)
AT (1) ATE432690T1 (https=)
AU (2) AU2006346318B2 (https=)
CA (1) CA2628806C (https=)
CY (1) CY1110480T1 (https=)
DE (1) DE602007001215D1 (https=)
DK (1) DK1889607T3 (https=)
ES (1) ES2327286T3 (https=)
HR (1) HRP20090350T1 (https=)
MA (1) MA31346B1 (https=)
PL (1) PL1889607T3 (https=)
PT (1) PT1889607E (https=)
RU (1) RU2419421C2 (https=)
SI (1) SI1889607T1 (https=)
WO (1) WO2008009756A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
IN2012DN05192A (https=) * 2010-01-21 2015-10-23 Aprea Ab
PT2377516E (pt) 2010-04-14 2012-07-02 Braun Melsungen Ag Composição acetaminofeno
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) * 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
EP3171868B1 (en) * 2014-07-25 2020-09-30 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
US20190029979A1 (en) * 2016-02-05 2019-01-31 Innopharma, Inc. Process of Manufacturing a Stable, Ready to Use Infusion Bag for an Oxidation Sensitive Formulation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440815A (en) 1981-06-29 1984-04-03 Abbott Laboratories Clear, autoclavable plastic formulation for medical liquid containers
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
KR100226191B1 (ko) 1997-04-03 1999-10-15 구광시 음료용 플라스틱 병
EP1027835B1 (en) * 1997-10-23 2008-09-17 Morinaga Milk Industry Co., Ltd. Method and apparatus for continuous heat sterilization of liquid
DE69719189T2 (de) 1997-11-18 2003-11-27 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
EE200400094A (et) 2001-12-18 2004-08-16 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratoires S.A. Paratsetamooli parenteraalne kompositsioon
AU2003235429A1 (en) 2002-05-27 2003-12-12 Kyorin Pharmaceutical Co., Ltd. (2s)-2-ethylphenylpropionic acid derivative
AU2003251152A1 (en) * 2002-07-03 2004-01-23 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production

Also Published As

Publication number Publication date
EP2100596A2 (en) 2009-09-16
JP4929352B2 (ja) 2012-05-09
EP2100596A3 (en) 2010-04-28
PT1889607E (pt) 2009-07-20
MA31346B1 (fr) 2010-05-03
AU2006346318A1 (en) 2008-01-24
CY1110480T1 (el) 2015-04-29
EP1889607A1 (en) 2008-02-20
WO2008009756A1 (es) 2008-01-24
AU2006346318B2 (en) 2011-02-10
RU2419421C2 (ru) 2011-05-27
US9943492B2 (en) 2018-04-17
DE602007001215D1 (de) 2009-07-16
CA2628806A1 (en) 2008-01-24
SI1889607T1 (sl) 2009-10-31
HRP20090350T1 (en) 2009-08-31
JP2009543851A (ja) 2009-12-10
US20090215903A1 (en) 2009-08-27
PL1889607T3 (pl) 2009-10-30
AU2011201253A1 (en) 2011-04-07
ATE432690T1 (de) 2009-06-15
EP1889607B1 (en) 2009-06-03
US9943479B2 (en) 2018-04-17
AU2011201253B2 (en) 2012-03-29
ES2327286T3 (es) 2009-10-27
RU2009105480A (ru) 2010-08-27
DK1889607T3 (da) 2009-07-27
US20160199325A1 (en) 2016-07-14

Similar Documents

Publication Publication Date Title
EP1889607B1 (en) Injectable liquid paracetamol formulation
EP2191826B1 (en) Pharmaceutical composition
DE60129823T2 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
DE69722580T2 (de) Neue stabile flüssige paracetamolmittel und verfahren zu deren herstellung
CN101808639A (zh) 抗真菌医药组合物
TWI500421B (zh) Pharmaceutical composition
Van de Louw et al. Inhibitory effects of hyperoxia and methemoglobinemia on H2S induced ventilatory stimulation in the rat
Bouma et al. Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A
EP2047855A1 (de) Antitumorale, antibakterielle und antivirale pharmazeutische zusammensetzung (varianten)
US20100203088A1 (en) Silver Nanoparticle Dispersion Formulation
EP2130796B1 (de) Wässrige Lösungen von reaktive Chlorverbindungen
EP4434580A2 (en) A stable aqueous hydroxycarbamide solution
DE69921832T2 (de) Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin
RS51179B (sr) Tečne injektabilne formulacije paracetamola
EP2832370A1 (en) Method for producing drugs and biologically active agents
EP2308463A1 (en) Aqueous acetaminophen compositions and method of preparation
EP2918291A2 (en) Pharmaceutical composition of stabilized paracetamol, plastic bags and use of the pharmaceutical composition
CN119385939A (zh) 一种左卡尼汀口服溶液及其制备方法
CN121221514A (zh) 二硫化硒凝胶及其制备方法
DE112008001612B4 (de) Antimikrobiell wirkende kosmetische und/oder pharmazeutische Zusammensetzungen zur topischen Anwendung, Verfahren zu deren Herstellung und ihre Anwendung in der Behandlung von Krankheiten
WO2013068405A1 (de) Zusammensetzung für die photodynamische diagnostik und therapie von tumoren
MXPA01009277A (en) Iodine preparation compositon
KR20030063040A (ko) 이중 코팅한 레티놀 팔미테이트 및 그를 함유하는 화장료조성물

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240715

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE

Effective date: 20250501

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250501

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250528

R14 Transfer of ownership recorded

Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250611

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 19TH ANNIV.) - STANDARD

Year of fee payment: 19

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250708

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250708